Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nicholson

Showing results (781-790 of 895) with videos related to

Pageof 90
Sort By:
Thorax|June 1, 2004
HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variationZ A Aziz, A U Wells, D M Hansell, et al.
The Journal of Pathology|December 5, 2012
LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma developmentLiwen Lu, Vitor H Teixeira, ZhengQiang Yuan, et al.
The Lancet. Respiratory Medicine|November 21, 2017
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White PaperDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
JCI Insight|June 9, 2016
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosisMark G Jones, Aurélie Fabre, Philipp Schneider, et al.
Plos One|January 17, 2025
Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral loadVasanthi Avadhanula, Chad J Creighton, Laura Ferlic-Stark, et al.
Nature Cancer|January 10, 2024
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinomaXiaoxi Pan, Khalid AbdulJabbar, Jose Coelho-Lima, et al.
Thorax|November 22, 2019
One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD)Steve Cunningham, Catriona Graham, Morag MacLean, et al.
JAMA|November 25, 2010
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trialJouke T Annema, Jan P van Meerbeeck, Robert C Rintoul, et al.
Thorax|April 23, 2016
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFPaul F Mercer, Hannah V Woodcock, Jessica D Eley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2015
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 ClassificationWilliam D Travis, Elisabeth Brambilla, Andrew G Nicholson, et al.
Pageof 90

Showing results (781-790 of 895) with videos related to

Sort By:
Pageof 90
Thorax|June 1, 2004
HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variationZ A Aziz, A U Wells, D M Hansell, et al.
The Journal of Pathology|December 5, 2012
LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma developmentLiwen Lu, Vitor H Teixeira, ZhengQiang Yuan, et al.
The Lancet. Respiratory Medicine|November 21, 2017
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White PaperDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
JCI Insight|June 9, 2016
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosisMark G Jones, Aurélie Fabre, Philipp Schneider, et al.
Plos One|January 17, 2025
Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral loadVasanthi Avadhanula, Chad J Creighton, Laura Ferlic-Stark, et al.
Nature Cancer|January 10, 2024
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinomaXiaoxi Pan, Khalid AbdulJabbar, Jose Coelho-Lima, et al.
Thorax|November 22, 2019
One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD)Steve Cunningham, Catriona Graham, Morag MacLean, et al.
JAMA|November 25, 2010
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trialJouke T Annema, Jan P van Meerbeeck, Robert C Rintoul, et al.
Thorax|April 23, 2016
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFPaul F Mercer, Hannah V Woodcock, Jessica D Eley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2015
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 ClassificationWilliam D Travis, Elisabeth Brambilla, Andrew G Nicholson, et al.
Pageof 90